Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High Dosage Esomeprazole and Baclofen for Therapy of Gastroesophageal Reflux Disease

NCT00461604 is registered in ClinicalTrials.gov with Technical University of Munich as lead sponsor.

NCT NCT00461604
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00461604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High Dosage Esomeprazole and Baclofen for Therapy of Gastroesophageal Reflux Disease
Lead sponsor
Technical University of Munich
Phase
Observational
Overall status
Completed
Start date
October 31, 2006
Completion date
May 31, 2008
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patients with persistent objectified gastroesophageal reflux and reflux-associated symptoms despite ppi-therapy with 40mg esomeprazole